Global Coronary Intervention Drug Eluting Stent Market Research Report 2021

1 Coronary Intervention Drug Eluting Stent Market Overview

• 1.1 Product Overview and Scope of Coronary Intervention Drug Eluting Stent
• 1.2 Coronary Intervention Drug Eluting Stent Segment by Type
  • 1.2.1 Global Coronary Intervention Drug Eluting Stent Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Below 40 µm
  • 1.2.3 40 µm- 65 µm
  • 1.2.4 Above 65 µm
• 1.3 Coronary Intervention Drug Eluting Stent Segment by Application
  • 1.3.1 Coronary Intervention Drug Eluting Stent Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Coronary Intervention Drug Eluting Stent Market Size Estimates and Forecasts
  • 1.4.1 Global Coronary Intervention Drug Eluting Stent Revenue 2016-2027
  • 1.4.2 Global Coronary Intervention Drug Eluting Stent Sales 2016-2027
  • 1.4.3 Coronary Intervention Drug Eluting Stent Market Size by Region: 2016 Versus 2021 Versus 2027

2 Coronary Intervention Drug Eluting Stent Market Competition by Manufacturers

• 2.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Coronary Intervention Drug Eluting Stent Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Coronary Intervention Drug Eluting Stent Manufacturing Sites, Area Served, Product Type
• 2.5 Coronary Intervention Drug Eluting Stent Market Competitive Situation and Trends
  • 2.5.1 Coronary Intervention Drug Eluting Stent Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Coronary Intervention Drug Eluting Stent Players Market Share by Revenue
  • 2.5.3 Global Coronary Intervention Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Coronary Intervention Drug Eluting Stent Retrospective Market Scenario by Region

• 3.1 Global Coronary Intervention Drug Eluting Stent Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Coronary Intervention Drug Eluting Stent Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
  • 3.3.1 North America Coronary Intervention Drug Eluting Stent Sales by Country
  • 3.3.2 North America Coronary Intervention Drug Eluting Stent Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
  • 3.4.1 Europe Coronary Intervention Drug Eluting Stent Sales by Country
  • 3.4.2 Europe Coronary Intervention Drug Eluting Stent Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Coronary Intervention Drug Eluting Stent Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Coronary Intervention Drug Eluting Stent Sales by Region
  • 3.5.2 Asia Pacific Coronary Intervention Drug Eluting Stent Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
  • 3.6.1 Latin America Coronary Intervention Drug Eluting Stent Sales by Country
  • 3.6.2 Latin America Coronary Intervention Drug Eluting Stent Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Coronary Intervention Drug Eluting Stent Sales by Country
  • 3.7.2 Middle East and Africa Coronary Intervention Drug Eluting Stent Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Coronary Intervention Drug Eluting Stent Historic Market Analysis by Type

• 4.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)
• 4.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Type (2016-2021)
• 4.3 Global Coronary Intervention Drug Eluting Stent Price by Type (2016-2021)

5 Global Coronary Intervention Drug Eluting Stent Historic Market Analysis by Application

• 5.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)
• 5.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Application (2016-2021)
• 5.3 Global Coronary Intervention Drug Eluting Stent Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Synlas GmbH
  • 6.1.1 Synlas GmbH Corporation Information
  • 6.1.2 Synlas GmbH Description and Business Overview
  • 6.1.3 Synlas GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Synlas GmbH Product Portfolio
  • 6.1.5 Synlas GmbH Recent Developments/Updates
• 6.2 YILSON
  • 6.2.1 YILSON Corporation Information
  • 6.2.2 YILSON Description and Business Overview
  • 6.2.3 YILSON Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 YILSON Product Portfolio
  • 6.2.5 YILSON Recent Developments/Updates
• 6.3 BrosMed Medical
  • 6.3.1 BrosMed Medical Corporation Information
  • 6.3.2 BrosMed Medical Description and Business Overview
  • 6.3.3 BrosMed Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 BrosMed Medical Product Portfolio
  • 6.3.5 BrosMed Medical Recent Developments/Updates
• 6.4 SCITECH Medical
  • 6.4.1 SCITECH Medical Corporation Information
  • 6.4.2 SCITECH Medical Description and Business Overview
  • 6.4.3 SCITECH Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 SCITECH Medical Product Portfolio
  • 6.4.5 SCITECH Medical Recent Developments/Updates
• 6.5 Wellinq
  • 6.5.1 Wellinq Corporation Information
  • 6.5.2 Wellinq Description and Business Overview
  • 6.5.3 Wellinq Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Wellinq Product Portfolio
  • 6.5.5 Wellinq Recent Developments/Updates
• 6.6 Degania Silicone
  • 6.6.1 Degania Silicone Corporation Information
  • 6.6.2 Degania Silicone Description and Business Overview
  • 6.6.3 Degania Silicone Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Degania Silicone Product Portfolio
  • 6.6.5 Degania Silicone Recent Developments/Updates
• 6.7 Alvimedica
  • 6.6.1 Alvimedica Corporation Information
  • 6.6.2 Alvimedica Description and Business Overview
  • 6.6.3 Alvimedica Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Alvimedica Product Portfolio
  • 6.7.5 Alvimedica Recent Developments/Updates
• 6.8 Interventional Medical Device Solutions
  • 6.8.1 Interventional Medical Device Solutions Corporation Information
  • 6.8.2 Interventional Medical Device Solutions Description and Business Overview
  • 6.8.3 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Interventional Medical Device Solutions Product Portfolio
  • 6.8.5 Interventional Medical Device Solutions Recent Developments/Updates
• 6.9 Comed BV
  • 6.9.1 Comed BV Corporation Information
  • 6.9.2 Comed BV Description and Business Overview
  • 6.9.3 Comed BV Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Comed BV Product Portfolio
  • 6.9.5 Comed BV Recent Developments/Updates
• 6.10 iVascular
  • 6.10.1 iVascular Corporation Information
  • 6.10.2 iVascular Description and Business Overview
  • 6.10.3 iVascular Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 iVascular Product Portfolio
  • 6.10.5 iVascular Recent Developments/Updates
• 6.11 LEPU Medical
  • 6.11.1 LEPU Medical Corporation Information
  • 6.11.2 LEPU Medical Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.11.3 LEPU Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 LEPU Medical Product Portfolio
  • 6.11.5 LEPU Medical Recent Developments/Updates
• 6.12 Eurocor Tech GmbH
  • 6.12.1 Eurocor Tech GmbH Corporation Information
  • 6.12.2 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.12.3 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Eurocor Tech GmbH Product Portfolio
  • 6.12.5 Eurocor Tech GmbH Recent Developments/Updates
• 6.13 OrbusNeich
  • 6.13.1 OrbusNeich Corporation Information
  • 6.13.2 OrbusNeich Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.13.3 OrbusNeich Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 OrbusNeich Product Portfolio
  • 6.13.5 OrbusNeich Recent Developments/Updates
• 6.14 Endocor GmbH
  • 6.14.1 Endocor GmbH Corporation Information
  • 6.14.2 Endocor GmbH Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.14.3 Endocor GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Endocor GmbH Product Portfolio
  • 6.14.5 Endocor GmbH Recent Developments/Updates
• 6.15 Meril Life Sciences
  • 6.15.1 Meril Life Sciences Corporation Information
  • 6.15.2 Meril Life Sciences Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.15.3 Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Meril Life Sciences Product Portfolio
  • 6.15.5 Meril Life Sciences Recent Developments/Updates
• 6.16 Acrostak
  • 6.16.1 Acrostak Corporation Information
  • 6.16.2 Acrostak Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.16.3 Acrostak Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Acrostak Product Portfolio
  • 6.16.5 Acrostak Recent Developments/Updates
• 6.17 Boston Scientific Corporation
  • 6.17.1 Boston Scientific Corporation Corporation Information
  • 6.17.2 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.17.3 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Boston Scientific Corporation Product Portfolio
  • 6.17.5 Boston Scientific Corporation Recent Developments/Updates
• 6.18 B. Braun
  • 6.18.1 B. Braun Corporation Information
  • 6.18.2 B. Braun Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.18.3 B. Braun Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 B. Braun Product Portfolio
  • 6.18.5 B. Braun Recent Developments/Updates
• 6.19 Biotronik
  • 6.19.1 Biotronik Corporation Information
  • 6.19.2 Biotronik Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.19.3 Biotronik Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Biotronik Product Portfolio
  • 6.19.5 Biotronik Recent Developments/Updates
• 6.20 Abbott
  • 6.20.1 Abbott Corporation Information
  • 6.20.2 Abbott Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.20.3 Abbott Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.20.4 Abbott Product Portfolio
  • 6.20.5 Abbott Recent Developments/Updates
• 6.21 MicroPort Medical Group
  • 6.21.1 MicroPort Medical Group Corporation Information
  • 6.21.2 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.21.3 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.21.4 MicroPort Medical Group Product Portfolio
  • 6.21.5 MicroPort Medical Group Recent Developments/Updates
• 6.22 Philips
  • 6.22.1 Philips Corporation Information
  • 6.22.2 Philips Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.22.3 Philips Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.22.4 Philips Product Portfolio
  • 6.22.5 Philips Recent Developments/Updates
• 6.23 Terumo Corporation
  • 6.23.1 Terumo Corporation Corporation Information
  • 6.23.2 Terumo Corporation Coronary Intervention Drug Eluting Stent Description and Business Overview
  • 6.23.3 Terumo Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
  • 6.23.4 Terumo Corporation Product Portfolio
  • 6.23.5 Terumo Corporation Recent Developments/Updates

7 Coronary Intervention Drug Eluting Stent Manufacturing Cost Analysis

• 7.1 Coronary Intervention Drug Eluting Stent Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Coronary Intervention Drug Eluting Stent
• 7.4 Coronary Intervention Drug Eluting Stent Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Coronary Intervention Drug Eluting Stent Distributors List
• 8.3 Coronary Intervention Drug Eluting Stent Customers

9 Coronary Intervention Drug Eluting Stent Market Dynamics

• 9.1 Coronary Intervention Drug Eluting Stent Industry Trends
• 9.2 Coronary Intervention Drug Eluting Stent Growth Drivers
• 9.3 Coronary Intervention Drug Eluting Stent Market Challenges
• 9.4 Coronary Intervention Drug Eluting Stent Market Restraints

10 Global Market Forecast

• 10.1 Coronary Intervention Drug Eluting Stent Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Coronary Intervention Drug Eluting Stent by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Coronary Intervention Drug Eluting Stent by Type (2022-2027)
• 10.2 Coronary Intervention Drug Eluting Stent Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Coronary Intervention Drug Eluting Stent by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Coronary Intervention Drug Eluting Stent by Application (2022-2027)
• 10.3 Coronary Intervention Drug Eluting Stent Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Coronary Intervention Drug Eluting Stent by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Coronary Intervention Drug Eluting Stent by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List